P

Assignee

IMMUNEX CORP

US432 patents

Top patents by PatentIndex Score

US7411050B2Aug 12, 2008

Monoclonal blocking antibody to human RANKL

IMMUNEX CORP94 citations99
US6740522B2May 25, 2004

Antibodies against ligand for receptor activator of NF-kB

IMMUNEX CORP123 citations99
US6727225B2Apr 27, 2004

TWEAK receptor

IMMUNEX CORP202 citations99
US6572852B2Jun 3, 2003

Method for suppressing inflammatory responses by administering TNFR

IMMUNEX CORP83 citations99
US6413932B1Jul 2, 2002

Tek antagonists comprising soluble tek extracellular binding domain

IMMUNEX CORP176 citations99
US6284236B1Sep 4, 2001

Cytokine that induces apoptosis

IMMUNEX CORP117 citations99
US6242213B1Jun 5, 2001

Isolated DNA molecules encoding RANK-L

IMMUNEX CORP95 citations99
US6232447B1May 15, 2001

Antibody immunoreactive with a human cytokine designated LERK-6

IMMUNEX CORP166 citations99
US6087329AJul 11, 2000

CD40 ligand polypeptide

IMMUNEX CORP122 citations99
US6017729AJan 25, 2000

Receptor activator of NF-κB

IMMUNEX CORP133 citations99
US5969110AOct 19, 1999

Antibodies that bind hek ligands

IMMUNEX CORP154 citations99
US5763223AJun 9, 1998

DNA encoding a cytokine that induces apoptosis

IMMUNEX CORP231 citations99
US5488032AJan 30, 1996

Method of using soluble human interleukin-1 receptors to suppress inflammation

IMMUNEX CORP124 citations99
US5395760AMar 7, 1995

DNA encoding tumor necrosis factor-α and -β receptors

IMMUNEX CORP259 citations99
US5180812AJan 19, 1993

Soluble human interleukin-1 receptors, compositions and method of use

IMMUNEX CORP163 citations99
US4968607ANov 6, 1990

Interleukin-1 receptors

IMMUNEX CORP357 citations99
US7648702B2Jan 19, 2010

Stable aqueous formulation of a soluble TNF receptor and arginine

IMMUNEX CORP123 citations98
US6716587B2Apr 6, 2004

Antibodies to interleukin-4 receptors and uses thereof

IMMUNEX CORP93 citations98
US6596852B2Jul 22, 2003

Antibodies that bind the cytokine designated LERK-5

IMMUNEX CORP190 citations98
US6541610B1Apr 1, 2003

Fusion proteins comprising tumor necrosis factor receptor

IMMUNEX CORP103 citations98
US6355779B1Mar 12, 2002

Cytokine designated 4-1BB ligand antibodies and human receptor that binds thereto

IMMUNEX CORP166 citations98
USRE36755EJun 27, 2000

DNA encoding tumor necrosis factor-α and -β receptors

IMMUNEX CORP94 citations98
US5856296AJan 5, 1999

DNA encoding interleukin-4 receptors

IMMUNEX CORP107 citations98
US5843423ADec 1, 1998

Methods of stimulating hematopoietic cells with flt3-ligand

IMMUNEX CORP95 citations98
US5728813AMar 17, 1998

Antibodies directed against elk ligand

IMMUNEX CORP165 citations98
US5717072AFeb 10, 1998

Antibodies that are immunoreactive with interleukin-4 receptors

IMMUNEX CORP119 citations98
US5674492AOct 7, 1997

Method of preventing or treating disease characterized by neoplastic cells expressing CD40

IMMUNEX CORP126 citations98
US5599905AFeb 4, 1997

Interleukin-4 receptors

IMMUNEX CORP143 citations98
US5480981AJan 2, 1996

CD30 ligand

IMMUNEX CORP259 citations98
US5457035AOct 10, 1995

Cytokine which is a ligand for OX40

IMMUNEX CORP331 citations98
US5199942AApr 6, 1993

Method for improving autologous transplantation

IMMUNEX CORP558 citations98
US5078996AJan 7, 1992

Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor

IMMUNEX CORP233 citations98
US5073627ADec 17, 1991

Fusion proteins comprising GM-CSF and IL-3

IMMUNEX CORP398 citations98
US5011912AApr 30, 1991

Hybridoma and monoclonal antibody for use in an immunoaffinity purification system

IMMUNEX CORP519 citations98
US4965195AOct 23, 1990

Interleukin-7

IMMUNEX CORP291 citations98
US4851341AJul 25, 1989

Immunoaffinity purification system

IMMUNEX CORP224 citations98
US4560655ADec 24, 1985

Serum-free cell culture medium and process for making same

IMMUNEX CORP1,146 citations98
US7638606B2Dec 29, 2009

Antibodies that bind interleukin-4 receptor

IMMUNEX CORP60 citations97
US7317090B2Jan 8, 2008

Antibodies to Interleukin-4 receptors and uses thereof

IMMUNEX CORP59 citations97
US7261894B2Aug 28, 2007

Methods of treating inflammatory and/or autoimmune disease

IMMUNEX CORP63 citations97
US7186809B2Mar 6, 2007

Methods and compositions relating to anti-interleukin-4 receptor antibodies

IMMUNEX CORP148 citations97
US6924124B1Aug 2, 2005

Feeding strategies for cell culture

IMMUNEX CORP109 citations97
US6562948B2May 13, 2003

Receptor activator of NF-κB

IMMUNEX CORP50 citations97
US6419929B1Jul 16, 2002

Recombinant RANK-L polypeptide

IMMUNEX CORP65 citations97
US6413744B1Jul 2, 2002

Methods and host cells for improved cell culture

IMMUNEX CORP88 citations97
US6264951B1Jul 24, 2001

Methods of inhibiting CD40L binding to CD40 with soluble monomeric CD40L

IMMUNEX CORP86 citations97
US6072047AJun 6, 2000

Receptor that binds trail

IMMUNEX CORP138 citations97
US5962406AOct 5, 1999

Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same

IMMUNEX CORP96 citations97
US5869286AFeb 9, 1999

Receptor that binds IL-17

IMMUNEX CORP81 citations97
US5767064AJun 16, 1998

Soluble type II interleukin-1 receptors and methods

IMMUNEX CORP79 citations97

Showing the top 50 of 432 patents by PatentIndex Score.